Indeed, cordycepin, an agent with limited stability in vivo prolongs survival in a CML cell line-derived mouse model, most likely via the suppression of CDH2.21 This evidence concerns the gene CDH2 and chronic myelogenous leukemia, BCR-ABL1 positive.